Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities
March 23, 2024 at 15:00 PM EDT
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.
